Jane J. Zara

Array ( [id] => 12676021 [patent_doc_number] => 20180117173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => METHOD OF TARGETING SENESCENT CELLS [patent_app_type] => utility [patent_app_number] => 15/573550 [patent_app_country] => US [patent_app_date] => 2016-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28140 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15573550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11270805 [patent_doc_number] => 20160333352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-17 [patent_title] => '5\' TRIPHOSPHATE OLIGONUCLEOTIDE WITH BLUNT END AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/151254 [patent_app_country] => US [patent_app_date] => 2016-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 35836 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15151254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13026809 [patent_doc_number] => 10036021 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-31 [patent_title] => 5' triphosphate oligonucleotide with blunt end and uses thereof [patent_app_type] => utility [patent_app_number] => 15/151057 [patent_app_country] => US [patent_app_date] => 2016-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 33 [patent_no_of_words] => 32491 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15151057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13462361 [patent_doc_number] => 20180282723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF ANTITHROMBIN 3 (AT3) BY DOUBLE-STRANDED RNA [patent_app_type] => utility [patent_app_number] => 15/572663 [patent_app_country] => US [patent_app_date] => 2016-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 109472 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -74 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15572663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15228193 [patent_doc_number] => 10501811 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-10 [patent_title] => Method for sorting tissue cells [patent_app_type] => utility [patent_app_number] => 15/568209 [patent_app_country] => US [patent_app_date] => 2016-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 12092 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15568209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16482420 [patent_doc_number] => 20200376020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => C/EBP ALPHA SARNA COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 15/568139 [patent_app_country] => US [patent_app_date] => 2016-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67508 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15568139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12286837 [patent_doc_number] => 09932606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-03 [patent_title] => Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the same [patent_app_type] => utility [patent_app_number] => 15/098342 [patent_app_country] => US [patent_app_date] => 2016-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4307 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 644 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15098342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11115210 [patent_doc_number] => 20160312183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-27 [patent_title] => 'AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 15/089016 [patent_app_country] => US [patent_app_date] => 2016-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 33590 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15089016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13853855 [patent_doc_number] => 10188633 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-29 [patent_title] => Identification of small molecules that facilitate therapeutic exon skipping [patent_app_type] => utility [patent_app_number] => 15/085801 [patent_app_country] => US [patent_app_date] => 2016-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 18199 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15085801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11107898 [patent_doc_number] => 20160304868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'COMPOSITIONS OF ASYMMETRIC INTERFERING RNA AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/081559 [patent_app_country] => US [patent_app_date] => 2016-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24214 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15081559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10997694 [patent_doc_number] => 20160194640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'DESIGN AND CONSTRUCTION OF BIFUNCTIONAL SHORT HAIRPIN RNA' [patent_app_type] => utility [patent_app_number] => 15/076376 [patent_app_country] => US [patent_app_date] => 2016-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12183 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15076376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13383803 [patent_doc_number] => 20180243443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => NANOPARTICLE CONJUGATES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/553855 [patent_app_country] => US [patent_app_date] => 2016-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18333 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11047801 [patent_doc_number] => 20160244759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'COMPOSITIONS AND TREATMENTS BASED ON CADHERIN MODULATION' [patent_app_type] => utility [patent_app_number] => 15/057958 [patent_app_country] => US [patent_app_date] => 2016-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 38363 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15057958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12227690 [patent_doc_number] => 09914926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-13 [patent_title] => 'Fidgetin-like 2 as a target to enhance wound healing' [patent_app_type] => utility [patent_app_number] => 15/057480 [patent_app_country] => US [patent_app_date] => 2016-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7380 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15057480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12138498 [patent_doc_number] => 20180016581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-18 [patent_title] => 'NUCLEIC ACID COMPOUNDS FOR BINDING GROWTH DIFFERENTIATION FACTOR 8' [patent_app_type] => utility [patent_app_number] => 15/545755 [patent_app_country] => US [patent_app_date] => 2016-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15236 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10797783 [patent_doc_number] => 20160143939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'COMPOSITIONS, KITS AND METHODS FOR TREATMENT OF CARDIOVASCULAR,IMMUNOLOGICAL AND INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 15/012052 [patent_app_country] => US [patent_app_date] => 2016-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19585 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10989233 [patent_doc_number] => 20160186179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in Vivo or in Vitro' [patent_app_type] => utility [patent_app_number] => 15/010837 [patent_app_country] => US [patent_app_date] => 2016-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 49270 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15010837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12043449 [patent_doc_number] => 09821034 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-21 [patent_title] => 'Combination therapy' [patent_app_type] => utility [patent_app_number] => 15/007011 [patent_app_country] => US [patent_app_date] => 2016-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23334 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15007011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11115255 [patent_doc_number] => 20160312228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-27 [patent_title] => 'METHOD OF INDUCING AN IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 15/005940 [patent_app_country] => US [patent_app_date] => 2016-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11783 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15005940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12409275 [patent_doc_number] => 09970025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Gene expression system using alternative splicing in insects [patent_app_type] => utility [patent_app_number] => 14/991825 [patent_app_country] => US [patent_app_date] => 2016-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 70 [patent_no_of_words] => 31849 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14991825 [rel_patent_id] =>[rel_patent_doc_number] =>)